Flywheel for
Flywheel’s imaging data management and analysis platform is purpose-built for BioPharma companies like Bristol Myers Squibb who are conducting multisite neuroscience and oncology programs and need to accelerate drug development and research workflows.
We’re working with 10 of the top 20 biopharma companies to ensure they maximize the value of their imaging data for secondary endpoint analysis, biomarker extraction, and faster clinical trial decisions. Connect with our experts to explore how your team can:
- Streamline imaging data management by centralizing ingestion, curation, BIDS/DICOM standardization and annotation for AI-ready CT/MR datasets
- Expedite your AI model development capabilities and optimize your investment in your NVIDIA DGX SuperPOD by preparing AI-ready datasets on Flywheel
- Accelerate and standardize your data curation and harmonization pipelines by automating processing with Flywheel Gears, containerized algorithms that run GPU-accelerated models for imaging-specific tasks
Learn how multicenter studies such as BMS’ ADEPT-2 trial (NCT06126224) could benefit from a validated imaging platform that provides audit trails, project locking and more — for FDA compliance and reproducible results.
Schedule a Demo
Fill out the form and we’ll reach out within 1 business day.
Keep Exploring
View All Resources
Enabling Near-Real-Time Clinical Trials
The FDA just took major steps toward making real-time clinical trials (RTCT) a reality. In short, it has enabled a framework in which safety signals and trial…
10 Essential Flywheel Gears to Supercharge Your Imaging Workflows
One of the most exciting features of the Flywheel medical imaging data management platform is the ability to leverage Gears, which are vetted, containerized algorithms that run within the system…
Behind the Software: Flywheel Engineer Profiles – Nicolas Pannetier, Director, Scientific Solutions Engineering
Quick facts Five years with Flywheel Expertise in medical imaging and signal analysis, clinical trials and data science Originally from…